
This medicinal product is manufactured by Lucius Pharmaceuticals and has been approved by the National Medical Products Administration (NMPA) for marketing in China. As an alternative to the innovator erlotinib, it is indicated for the corresponding indications.

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: